🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This phase I trial tests the effect of allogeneic Orca-Q stem cell transpla...
Status
Not Yet Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2026-09-01
Trial ID
NCT07759102
This phase I/II trial studies the side effects and best dose of temozolomid...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2009-02-25
Trial ID
NCT00669669
Treatments Being Tested
Phase II trial to study the effectiveness of combination chemotherapy and p...
Status
Terminated
Location
Gynecologic Oncology Group
Start Date
1999-11
Trial ID
NCT00004221
This randomized phase III trial studies how well gemcitabine hydrochloride ...
Status
Terminated
Location
Tennessee Valley Gynecologic Oncology
Start Date
2012-06-04
Trial ID
NCT01533207
Sickle cell anemia is a genetic disorder that results from a single nucleot...
Status
Completed
Location
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Start Date
2000-03
Trial ID
NCT00005783
Treatments Being Tested
This phase I/II trial studies the safety, side effects, and best dose of de...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-09-23
Trial ID
NCT06928662
This phase II trial studies how well giving cyclophosphamide and anti-thymo...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2011-09-15
Trial ID
NCT01413100